Chapter 5 Drug Promotion, Clinical Trials, and Conflicts of Interest "Gifts buy you time with a doc, time that might change his mind. . . .Money is the big resource.…

Slide 1FIRST PRINCIPLES – SECOND DRAFT Charles Medawar, Social Audit Ltd 1 Community predicates personal health 2 Health outcomes matter above all 3 Real health implies…

Slide 1Regulation of Pharmaceutical Promotion: assessment, analysis & advocacy Lilia Ziganshina 20 May 2009 WHA Slide 2 1988: WHO Ethical Criteria 2007: Resolution on…

Slide 1Xiao Xia Hu PhD Associate Professor Shandong University Centre for Health Management and Policy Research [email protected] 27th Oct 2006 HAI Europe 25th Anniversary Conference…

1. ANVISAAgencia Nacional de VigilanciaSanitariaBy Prashant Patel(M.pharm sem-2)Department of pharmaceuticaltechnologyIndukaka Ipcowala college of pharmacy 2. Background…

1. Denis Kibira/Patrick Mubangizi HEPS Uganda/HAI-Afica Access to Medicines 2. Objectives of presentation To understand What is meant by Essential Medicines Components of…

1. Trends in Performance of Japanese Companies under the Global ESG Rating Models Tomohiro Matsuoka Head of Research, SIRIS,Australia 2. Global SRI Research Traditionally,…

Pharma Marketing Blog: The Year 2013 in Images These are my favorite images & posts from Pharma Marketing blog in 2014 the year 2014 in images Pharmaguy  2014. Pharma…

In the name of Allah, indefinitely beneficent, boundlessly merciful Noor Muhammad Mahar B.Pharm, LLB, M.A (International Relations) Media Secretary PPA Consultant â CEO…

1. ABUBAKAR DANBATTA RATIONAL DRUG USE 05/19/15 2. Outline Definition of rational use of medicines Rationale behind rational use of medicines Reasons of irrational…